Last edition
News about
Glenmark Signs Exclusive Marketing and Distribution Deal with BeiGene
Glenmark has signed an exclusive marketing and distribution agreement with BeiGene, a global oncology company.
Sanofi, Formation Bio and OpenAI to Develop AI-Powered Software
Sanofi, Formation Bio and OpenAI have announced their collaboration to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently.
Biocon Biologics Gets FDA Approval for Biosimilar Aflibercept for Yesafili
Biocon Biologics Ltd (BBL) has announced that the US Food and Drug Administration (US FDA) has approved the company’s first-to-file application for Yesafili.
Astellas Pharma and YASKAWA Sign MOU to Explore Innovative Cell Therapy Ecosystem
Astellas will contribute cell manufacturing technology, clinical development, and regulatory insights related to cell therapy, while YASKAWA will provide and develop robotics and factory automation technologies.
YGION Biomedical Secures EUR 15 Million in Series A Financing for YGNITE
The funds will be used to further develop YGION's innovative YGNITE™ technology platform and advance their lead program, YG-01, into preclinical and clinical stages.
AmplifyBio, Xcellbio to Manufacture Solid Tumor-Targeting TCR-T Cell Therapy
Xcell Biosciences Inc. (Xcellbio) has collaborated with AmplifyBio to streamline and improve the manufacturing process for engineered T-cell receptor (TCR) therapies targeting solid tumors.
Phastar and Beaconcure to Deliver Process Revolution in Clinical Data Review
Beaconcure Inc. has inked a strategic partnership with Phastar Inc. to enhance clinical review processes in clinical trials.
Chroma Medicine Appoints Jenny Marlowe, Ph.D., as Chief Development Officer
Dr. Marlowe joins Chroma from Solid Biosciences (previously AvantiBio), where she was the Chief Scientific Officer, leading discovery, research, and translational development.
AstraZeneca to Establish USD 1.5 Billion Manufacturing Facility for ADCs in Singapore
AstraZeneca has decided to build a USD 1.5 billion manufacturing facility in Singapore for antibody-drug conjugates (ADCs), enhancing the global supply of its ADC portfolio.
Shoulder Innovations Introduces InSet 95 Humeral Stem
This product is designed to enhance surgical outcomes and improve patient recovery for those suffering from poor bone quality.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy